Skip to main content

MoneyWorks4Me

Aurobindo Pharma informs about press release

27 Aug 2021 Evaluate

Aurobindo Pharma has informed that it enclosed a copy of the Press Release on 27th August 2021 in connection with USFDA approval received by Eugia Pharma Specialities Limited, a wholly owned subsidiary of the Company, for Cyclophosphamide Injection.

The above information is a part of company’s filings submitted to BSE.



Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..